Home › Thyroid Diseases
Thyroid Diseases clinical trials recruiting in the U.S.
10 studies for Thyroid Diseases are recruiting participants at sites across the United States.
The thyroid is a gland in the neck. The thyroid gland creates hormones that affect metabolism. Learn about thyroid diseases, such as hypothyroidism.
Cities with the most studies
- Houston, TX5 studies
- New York City, NY4 studies
- Memphis, TN3 studies
- Boston, MA3 studies
- Dallas, TX3 studies
- Miami, FL3 studies
By state
- California5 studies
- Florida5 studies
- Georgia3 studies
- Massachusetts3 studies
- New York4 studies
- Ohio4 studies
- Tennessee4 studies
- Texas5 studies
Recently updated studies
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04913285Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649Hereditary Risk Factors for Thyroid Cancer
RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Jun 11, 2026 · NCT02747888A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05733013Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT04615988A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jan 5, 2026 · NCT06345339A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
Recruiting
Ages 18 to 75 · All sexes · Updated Sep 8, 2025 · NCT03977207Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Feb 25, 2025 · NCT06112340Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2019 · NCT03050762From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.